Hormones and hormonal mechanisms
FDA approved postmenopausal breast cancer; Phase II/III for other sites Steroidal aromatase inhibitor. Pharmacia, Pfizer. For adjuvant treatment of postmenopausal women with ER positive breast cancer who have completed 2-3 years of tamoxifen for completion of a total of 5 consecutive years of adjuvant hormonal therapy.
This drug should be coded